S. Krege

8.4k total citations · 1 hit paper
140 papers, 3.4k citations indexed

About

S. Krege is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Krege has authored 140 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Surgery, 28 papers in Molecular Biology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Krege's work include Testicular diseases and treatments (59 papers), Bladder and Urothelial Cancer Treatments (29 papers) and Sexual Differentiation and Disorders (21 papers). S. Krege is often cited by papers focused on Testicular diseases and treatments (59 papers), Bladder and Urothelial Cancer Treatments (29 papers) and Sexual Differentiation and Disorders (21 papers). S. Krege collaborates with scholars based in Germany, United States and Switzerland. S. Krege's co-authors include H. Rübben, Martin C. Michel, Peter Albers, Axel Heidenreich, Sabine Kliesch, Μ. Goepel, T. Otto, Michael Hartmann, Charlotte Fetscher and Tim Schneider and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

S. Krege

126 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

2009 465 citations S. Krege et al. European Urology profile →

Peers

Countries citing papers authored by S. Krege

Since Specialization

Citations

This map shows the geographic impact of S. Krege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Krege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Krege more than expected).

Fields of papers citing papers by S. Krege

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Krege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Krege. The network helps show where S. Krege may publish in the future.

Co-authorship network of co-authors of S. Krege

This figure shows the co-authorship network connecting the top 25 collaborators of S. Krege. A scholar is included among the top collaborators of S. Krege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Krege. S. Krege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influence of lymph node degeneration on metastases in prostate cancer: or why we must look for a needle in a haystack 2023 ·BMC Urology ·Daniel Gödde, Stephan Degener, (unknown), (unknown), (unknown), (unknown), Friedrich‐Carl von Rundstedt, Hans Michael Kvasnicka, S. Krege, Stephan Störkel	1
2	Urologie 2030: Die dringende Notwendigkeit die Digitalisierung in der Urologie schon jetzt voranzutreiben um die medizinische Versorgung aufrecht erhalten zu können – ein Expertenkonsens 2023 ·Aktuelle Urologie ·Johannes Huber, Hendrik Borgmann, Kurt Miller, Axel S. Merseburger, S. Krege, Christian Gratzke	1
3	Long-Term Results of Surgical Treatment and Patient-Reported Outcomes in Congenital Adrenal Hyperplasia—A Multicenter European Registry Study 2022 ·Journal of Clinical Medicine ·S. Krege, Henrik Falhammar, Hildegard Lax, Robert Roehle, Hedi L. Claahsen‐van der Grinten, Barbara Kortmann, Lise Duranteau, Agneta Nordenskjöld	11
4	Therapy of clinical stage IIA and IIB seminoma: a systematic review 2021 ·World Journal of Urology ·Julia Heinzelbecker, Stefanie Schmidt, (unknown), Jonas Busch, Carsten Bokemeyer, Johannes Claßen, Annette Dieing, Oliver W. Hakenberg, S. Krege, Alexandros Papachristofilou, David Pfister, Christian Ruf, Hans Schmelz, Heinz Schmidberger, Rainer Souchon, Christian Winter, Friedemann Zengerling, Sabine Kliesch, Peter Albers, Christoph Oing	9
5	Reformen in der Behandlung von Menschen mit Varianten der Geschlechtsdifferenzierung 2020 ·Der Urologe ·S. Krege	2
6	Ileal vaginoplasty as vaginal reconstruction in transgender women and patients with disorders of sex development: an international, multicentre, retrospective study on surgical characteristics and outcomes 2018 ·British Journal of Urology ·Wouter B. van der Sluis, Nicola Pavan, Giovanni Liguori, Stefano Bucci, Marta Bižić, Vladimir Kojović, Jochen Heß, W. J. H. J. Meijerink, Margriet G. Mullender, Müjde Özer, Jan Maerten Smit, Marlon E. Buncamper, S. Krege, Miroslav L. Djordjević, Carlo Trombetta, Mark‐Bram Bouman	20
7	Diagnostik, Therapie und Nachsorge beim Hodentumor 2017 ·Der Urologe ·S. Krege	3
8	Interdisciplinary Evidence-Based Recommendations for the Follow-Up of Early Stage Seminomatous Testicular Germ Cell Cancer Patients 2011 ·Strahlentherapie und Onkologie ·Rainer Souchon, Michael Hartmann, S. Krege, Anja Lorch, Frank Mayer, Maria De Santis, Silke Gillessen, J. Beyer, Richard Cathomas	7
9	Störungen der Sexualentwicklung und Identität im Kindes- und Jugendalter 2011 ·Der Urologe ·S. Krege	1
10	Die Target-Therapie urologischer Tumoren 2010 ·Der Urologe ·Mario W. Kramer, S. Krege, Inga Peters, Axel S. Merseburger, M.A. Kuczyk	6
11	Netzwerk DSD/Intersexualität 2007 ·Der Urologe ·Ute Thyen, S. Krege	2
12	Management kutaner Metastasen 2007 ·Der Urologe ·(unknown), F. vom Dorp, S. Krege, H. Rübben	3
13	Der Hodentumor: gestern – heute – morgen 2006 ·Der Urologe ·S. Krege, Ch. Wittekind, Rainer Souchon, Friedemann Honecker, Carsten Bokemeyer, Peter Albers, (unknown), H. Rübben	1
14	Geriatrische Urologie - Tumorerkrankungen 2006 ·Aktuelle Urologie ·S. Krege, Claire Friedrich, Ludger Pientka, H. Rübben	1
15	Interdisziplinärer Konsensus zur Diagnostik und Therapie von Hodentumoren Ergebnisse einer Update-Konferenz auf Grundlage evidenzbasierter Medizin (EBM) 2001 ·Der Urologe ·S. Krege, Hans‐Joachim Schmoll, Rainer Souchon	2
16	Interdisziplinärer Konsensus zur Diagnostik und Therapie von Hodentumoren Ergebnisse einer Update-Konferenz auf Grundlage evidenzbasierter Medizin (EBM): Ergebnisse einer Update-Konferenz auf Grundlage evidenzbasierter Medizin (EBM) 2000 ·Strahlentherapie und Onkologie ·Rainer Souchon, S. Krege, Hans‐Joachim Schmoll, Peter Albers, J. Beyer, Carsten Bokemeyer, Johannes Claßen, Klaus‐Peter Dieckmann, Michael Hartmann, Axel Heidenreich, W. Höltl, Sabine Kliesch, Kai-Uwe Köhrmann, (unknown), Heinz Schmidberger, (unknown), Eva Winter, Christian Wittekind, Michael Bamberg	1
17	Affinity of trazodone for human penile α ₁ ‐ andα ₂ ‐adrenoceptors 2000 ·British Journal of Urology ·S. Krege, Μ. Goepel, H. Sperling, Martin C. Michel	23
18	Interdisziplinärer Konsensus zur Diagnostik und Therapie von Hodentumoren Ergebnisse einer Update-Konferenz auf Grundlage evidenzbasierter Medizin (EBM) 2000 ·Strahlentherapie und Onkologie ·Rainer Souchon, S. Krege, Hans‐Joachim Schmoll, Peter Albers, J. Beyer, Carsten Bokemeyer, Johannes Claßen, Klaus‐Peter Dieckmann, Michael Hartmann, Axel Heidenreich, W. Höltl, Sabine Kliesch, Kai-Uwe Köhrmann, Markus A. Kuczyk, Heinz Schmidberger, (unknown), Eva Winter, Christian Wittekind, Michael Bamberg, (unknown)	10
19	Second-line chemotherapy with mitomycin-C and 5-fluorouracil in the treatment of refractory metastatic cancer of the urinary bladder 1997 ·Der Urologe ·T. Otto, S. Krege, Brandon Otto, Μ. Goepel, H. Rübben	3
20	Phase II Study: Adjuvant Single-Agent Carboplatin Therapy for Clinical Stage I Seminoma 1997 ·European Urology ·S. Krege, (unknown), T. Otto, Μ. Goepel, H. Rübben	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact